Investorideas.com - Viridian Announces the 'Future of Cannabis' Panel at the Upcoming Viridian Cannabis Industry Conference in Boston
October 11, 2017 (Investorideas.com Newswire) Viridian Capital Advisors, LLC, a New York City-based financial and strategic advisory firm dedicated to the cannabis industry, announces the "Future of Cannabis" panel at our upcoming session of the Viridian Cannabis Investment Series: The First Annual Comprehensive New England Conference - The Cannabis Industry, co-hosted with Burns & Levinson on October 17, 2017 at the Hilton Boston/Dedham.
Wednesday, October 11, 2017
StereoVision Entertainment, Inc. (OTC: $SVSN) Added to 420 #Cannabis Investor Ideas Directory
StereoVision Entertainment, Inc. (OTC: $SVSN) Added to 420 #Cannabis Investor Ideas Directory
Company Announces majority owned subsidiary CannaVision plans to open three medical cannabis and holistic pain management clinics
Pt. Roberts, WA; Delta, BC – October 11, 2017 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks, and its affiliated directorywww.420cannabisinvestorideas.com announce the most recent addition to the 420 Cannabis Investor Ideas Directory.
StereoVision Entertainment, Inc. (OTC:SVSN) a publicly traded Nevada corporation announced yesterday that their majority owned medical cannabis clinic and industrial hemp subsidiary CannaVision plans to open three medical cannabis and holistic pain management clinics in the Tampa Bay metropolitan area.
Read this news in full at
StereoVision Entertainment Inc. http://stereovision.com Headquartered in Las Vegas, Nevada StereoVision is a publicly traded Nevada corporation (OTC:SVSN) focused on creating, acquiring, and producing multimedia content with its media subsidiaries, the wholly owned 9 time Emmy Award - winning production company REZN8, http://rezn8.com, the majority - owned family entertainment company, Inspirational Vision Media, http://ivmi.biz and the majority - owned Florida medical marijuana clinic and industrial hemp corporation MediCannaVision Inc., dba CannaVision. http://cannavisionclinics.com
About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideaswww.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory. http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Contact Investorideas.com
800-665-0411
SinglePoint (OTC: $SING): UAHC Ventures, LLC Invests $600K in Mobile Technology Company Focused on Developing Bitcoin Payment System for Cannabis Industry
SinglePoint (OTC: $SING): UAHC Ventures, LLC Invests $600K in Mobile Technology Company Focused on Developing Bitcoin Payment System for Cannabis Industry
CHICAGO - October 11, 2017 (Investorideas.com Newswire) UAHC Ventures, LLC, a wholly-owned subsidiary of United American Healthcare Corporation ("UAHC Ventures"), announced today that it has invested $600,000 with SinglePoint, Inc (OTC:SING) ("SING") through the purchase of a Secured Promissory Note and Warrant.
Read this news in full at
About United American Healthcare Corporation
United American Healthcare Corporation ("UAHC"), through its subsidiary, UAHC Ventures, LLC, pursues strategic investment opportunities in various growth industries. Additionally, UAHC, through its subsidiary Pulse Systems, LLC, is a contract manufacturing company that provides services to the medical device industry. UAHC nor any of its existing subsidiaries are an "Investment Company" as defined by Section 3(a)(1) of the Investment Company Act of 1940 (the "Act") and are therefore not subject to the regulations contained in the Act.
Forward-looking Statements
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." All information set forth in this news release, except historical and factual information, represents forward-looking statements. This includes all statements about the Company's plans, beliefs, estimates and expectations. These statements are based on current estimates and projections, which involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These risks and uncertainties include issues related to: rapidly changing technology and evolving standards in the industries in which the Company and its subsidiaries operate; the ability to obtain sufficient funding to continue operations, maintain adequate cash flow, profitably exploit new business, license and sign new agreements; the unpredictable nature of consumer preferences; and other factors set forth in the Company's most recently filed annual report and registration statement. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Readers should carefully review the risks and uncertainties described in other documents that the Company files from time to time with the U.S. Securities and Exchange Commission.
Disclosure: SinglePoint, Inc. (OTC: $SING) is featured on the 420 Cannabis Investor Ideas of 2017 at www.420cannabisinvestorideas.com
SinglePoint, Inc. (OTC: SING) is a featured company on Investorideas.com
View the profile on Investorideas.com
View the profile on Investorideas.com
Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory and SING is also a paid featured cannabis and bitcoin company for news and PR social media
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Bitcoin, Blockchain and Digital Currency Stocks and ICO's
Like Bitcoin, Blockchain and Digital Currency Stocks? View our Bitcoin, Blockchain and Digital Currency Stocks Directory
Tuesday, October 10, 2017
#Cannabis News: (OTC: $SVSN) Subsidiary CannaVision Announces Plans to Open Three Medical Cannabis and Holistic Pain Management Clinics in the Tampa Bay Metropolitan Area
#Cannabis News: (OTC: $SVSN) Subsidiary CannaVision Announces Plans to Open Three Medical Cannabis and Holistic Pain Management Clinics in the Tampa Bay Metropolitan Area
LAS VEGAS, NEVADA - October 10, 2017 (Investorideas.com Newswire) StereoVision Entertainment, Inc. (OTC PINK: SVSN), a publicly traded Nevada corporation announced today that their majority owned medical cannabis clinic and industrial hemp subsidiary CannaVision plans to open three medical cannabis and holistic pain management clinics in the Tampa Bay metropolitan area.
Read this news in full at
“We’re seeing high demand for medical cannabis cards in Florida,” stated CannaVision President Marla Marloch. “We believe John Morgan, who has 100% support from CannaVision’s management and investors, will prevail in his efforts to allow the medical use of the whole marijuana plant by qualified medical marijuana patients in Florida. A victory for his lawsuit representing the freedom of choice for Florida’s qualified medical marijuana patients is expected to generate exponible growth in the number of people seeking qualification for medical marijuana cards. With this investment in Tampa Bay’s metropolitan area we’re continuing to grow our CannaVision Clinics footprint throughout the state.”
StereoVision Entertainment Inc. http://stereovision.com Headquartered in Las Vegas, Nevada StereoVision is a publicly traded Nevada corporation (OTC:SVSN) focused on creating, acquiring, and producing multimedia content with its media subsidiaries, the wholly owned 9 time Emmy Award - winning production company REZN8, http://rezn8.com, the majority - owned family entertainment company, Inspirational Vision Media, http://ivmi.biz and the majority - owned Florida medical marijuana clinic and industrial hemp corporation MediCannaVision Inc., dba CannaVision. http://cannavisionclinics.com
Safe Harbor Statement: Except for historical information certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company cautions that these forward-looking statements are qualified by other factors. The Company undertakes no obligation to publicly update any statements in this release.
Contact: Jack Honour 818-326-6018 info@stereovision.com
Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:
Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory
Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Watch the 420 Cannabis Investor video
Scythian Biosciences Corp.’s (TSXV: $SCYB.V) Professional Athlete Advisory Committee Head, NFL Star Bart Oates says, “Company has a winning team”
Scythian Biosciences Corp.’s (TSXV: $SCYB.V) Professional Athlete Advisory Committee Head, NFL Star Bart Oates says, “Company has a winning team”
October 10, 2017 – Investorideas.com, a global news source and investor resource covering cannabis and biotech stocks issues an exclusive podcast interview with NFL Champion Bart Oates, the first appointment of the Scythian Biosciences (TSX.V: SCYB) Professional Athlete Advisory Committee.
Oates, a five-time NFL Pro Bowl player and three-time Super Bowl Champion, was announced as the first appointee to the newly formed committee on October 2. Oates identified the strength of the team in all areas as a guide to why Scythian will be successful.
He also shares his personal experiences with concussions in the NFL and his education of the company’s treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination and how it can make a difference going forward.
Read this news in full at http://www.investorideas.com/CO/SCYB/news/2017/10101Podcast.asp
Hear the full podcast:
About Mr. Oates
A former center for the New York Giants and San Francisco 49ers, Bart Oates is a 5-time NFL Pro Bowl player and a 3-time Super Bowl Champion. Once finished with football, Mr. Oates took law classes and then worked as an attorney, receiving his law degree from Seton Hall University. Mr. Oates maintains an active role in many services to the community, including serving as President of the NY/NJ Chapter of the NFL Alumni Association.
Scythian ( http://scythianbio.com/) is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.
Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities.
Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami. Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in neurocognitive testing. Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995.
Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.
About Investorideas.com - News that Inspires Big Ideas
www.Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.
The Investorideas.com podcasts are also available on iTunes, Tunein, Stitcher. Spreaker.com, iHeart.com Radio and Google Play Music.
Visit the Podcast page at Investorideas.com: http://www.investorideas.com/Audio/
Subscribe to Investorideas.com Podcast RSS:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp
Visit Profile page: http://www.investorideas.com/CO/SCYB/
Contact Investorideas.com
800-665-0411
Wednesday, October 4, 2017
#Cannabis Stock News: Right On Brands (OTCQB: RTON) To Showcase Humbly Hemp at 2017 FounderMade Consumer Discovery Show
LOS ANGELES, CA - October 4, 2017 (Investorideas.com Newswire) Right On Brands, Inc. (OTCQB: RTON) announced today that Humbly Hemp will be exhibiting at the New York 2017 FounderMade Consumer Discovery Show in November. The FounderMade New York event is attended by many high profile media influencers, distributors, retailers, and investors who can help fast track a brand onto the road of success.
The FounderMade Summits are fast becoming the ultimate destination for entrepreneurs to build the business of their dreams. The Consumer Discovery Show connects a curated network of best-in-class entrepreneurs, founders, execs, press, bloggers, media influencers, distributors, retailers, and investors. Through the FounderMade platform, we take consumer discovery to the next level. Helping entrepreneurs everywhere scale their business through thought leadership, investment, distribution and high-impact marketing initiatives.
Confirmed buyers, investors, and influencers at this year's show include Whole Foods Markets, Urban Outfitters, Starbucks, CNBC, Huffington Post, Beechwood Capital and a whole host of Fortune 500 companies.
"FounderMade Consumer Discovery Show is an annual event that connects the founders of innovative brands with entrepreneurs in all stages of growth," states Daniel Crawford CEO. "This is a huge show and has been a launching pad for many major brands such as RXBar, FoodStirs and Bulletproof Coffee. With influential business leaders such as Target, Starbucks, Entrepreneur Magazine and Whole Foods, this is an enterprising opportunity for the brand to be seen by industry leaders."
Tickets are live so let the countdown begin! Get excited about FounderMade's NEW Consumer Discovery Show in NYC this November 17-18. All the details and your early bird tickets at foundermade.com/cds-2017.
For more information: http://www.foundermade.com/
About Humbly Hemp Bars:
Humbly Hemp snack bars are straightforward, delicious, and jam-packed with the best ingredients on earth. Each bar is kosher, vegan, soy free, dairy free, gluten-free, and free of all top 11 allergens. All our bars start with a base of Gluten Free Rolled Oats, Hemp seeds, and Plant Protein. We offer three flavors: Cinnamon Date, Berry Vanilla, and Cocoa + Sea Salt.
Within four months of our launch, Humbly Hemp has added over twenty-five retail locations in the Los Angeles area and signed a brokerage deal with Sunshine Specialties, an industry leader in the health and wellness space who has put us into talks with big-box retailers throughout the state of California. They have also signed agreements and are available on UrthMarket.Com, a new cutting-edge natural food online retailer.
Order from Humbly Hemp on Amazon: https://www.amazon.com/s/ref=bl_dp_s_web_0?ie=UTF8&search-alias=aps&field-keywords=Humbly+Hemp
About Right On Brands, Inc.:
Right On Brands, Inc., a Santa Monica, California based consumer and media company specializing in the brand development of health conscious, hemp-infused food and beverage products.
Humbly Hemp is a product line of delicious hemp-based products. The snack line will feature functional foods that will delight the palette of consumers and thrill retailers with Americas fastest growing food category.
Interested investors, our stock symbol has changed from HLTK to RTON.
Corporate Website: HumblyHemp.Com
Order product online and join our email list
To stay informed with up-to-the-minute details on the upcoming launch and local happenings, friends and fans of the hemp-friendly company can sign up for the Humbly Hemp Founders Club by visiting the official website:
http://www.HumblyHemp.com
Visit us on Facebook: https://www.facebook.com/humblyhemp/?fref=ts
Follow us on Twitter: https://twitter.com/HumblyHemp?lang=en
Visit us on Investors Hangout: http://investorshangout.com/HealthTalk-Live-Inc-HLTK-91651/
Investors Hangout is the only authorized Investors blog page for Health Talk Live, Inc.
Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions and capacity to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements to reflect events or circumstances that may arise after the date of this release.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure RTON is a featured PR, social media and news client on Investorideas.com effective July 27 2017 – More info: http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
The FounderMade Summits are fast becoming the ultimate destination for entrepreneurs to build the business of their dreams. The Consumer Discovery Show connects a curated network of best-in-class entrepreneurs, founders, execs, press, bloggers, media influencers, distributors, retailers, and investors. Through the FounderMade platform, we take consumer discovery to the next level. Helping entrepreneurs everywhere scale their business through thought leadership, investment, distribution and high-impact marketing initiatives.
Confirmed buyers, investors, and influencers at this year's show include Whole Foods Markets, Urban Outfitters, Starbucks, CNBC, Huffington Post, Beechwood Capital and a whole host of Fortune 500 companies.
"FounderMade Consumer Discovery Show is an annual event that connects the founders of innovative brands with entrepreneurs in all stages of growth," states Daniel Crawford CEO. "This is a huge show and has been a launching pad for many major brands such as RXBar, FoodStirs and Bulletproof Coffee. With influential business leaders such as Target, Starbucks, Entrepreneur Magazine and Whole Foods, this is an enterprising opportunity for the brand to be seen by industry leaders."
Tickets are live so let the countdown begin! Get excited about FounderMade's NEW Consumer Discovery Show in NYC this November 17-18. All the details and your early bird tickets at foundermade.com/cds-2017.
For more information: http://www.foundermade.com/
About Humbly Hemp Bars:
Humbly Hemp snack bars are straightforward, delicious, and jam-packed with the best ingredients on earth. Each bar is kosher, vegan, soy free, dairy free, gluten-free, and free of all top 11 allergens. All our bars start with a base of Gluten Free Rolled Oats, Hemp seeds, and Plant Protein. We offer three flavors: Cinnamon Date, Berry Vanilla, and Cocoa + Sea Salt.
Within four months of our launch, Humbly Hemp has added over twenty-five retail locations in the Los Angeles area and signed a brokerage deal with Sunshine Specialties, an industry leader in the health and wellness space who has put us into talks with big-box retailers throughout the state of California. They have also signed agreements and are available on UrthMarket.Com, a new cutting-edge natural food online retailer.
Order from Humbly Hemp on Amazon: https://www.amazon.com/s/ref=bl_dp_s_web_0?ie=UTF8&search-alias=aps&field-keywords=Humbly+Hemp
About Right On Brands, Inc.:
Right On Brands, Inc., a Santa Monica, California based consumer and media company specializing in the brand development of health conscious, hemp-infused food and beverage products.
Humbly Hemp is a product line of delicious hemp-based products. The snack line will feature functional foods that will delight the palette of consumers and thrill retailers with Americas fastest growing food category.
Interested investors, our stock symbol has changed from HLTK to RTON.
Corporate Website: HumblyHemp.Com
Order product online and join our email list
To stay informed with up-to-the-minute details on the upcoming launch and local happenings, friends and fans of the hemp-friendly company can sign up for the Humbly Hemp Founders Club by visiting the official website:
http://www.HumblyHemp.com
Visit us on Facebook: https://www.facebook.com/humblyhemp/?fref=ts
Follow us on Twitter: https://twitter.com/HumblyHemp?lang=en
Visit us on Investors Hangout: http://investorshangout.com/HealthTalk-Live-Inc-HLTK-91651/
Investors Hangout is the only authorized Investors blog page for Health Talk Live, Inc.
Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions and capacity to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements to reflect events or circumstances that may arise after the date of this release.
Disclosure: Right On Brands (OTCQB: RTON) is featured on the 420 Cannabis Investor Ideas Directory at www.420cannabisinvestorideas.com
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure RTON is a featured PR, social media and news client on Investorideas.com effective July 27 2017 – More info: http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Monday, October 2, 2017
Scythian Biosciences Corp. (TSXV: $SCYB.V) Announces Bart Oates, 5-time #NFL Pro Bowl player and a 3-time Super Bowl Champion Joins Professional Athlete Advisory Committee
TORONTO - October 2, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) announces the formation of its Professional Athlete Advisory Committee and the first appointment ,with Bart Oates, a 5-time NFL Pro Bowl player and a 3-time Super Bowl Champion joining the new Committee. The purpose of this committee is to bring together various, current, and former pro-athletes who have experienced or share concern for the pain and suffering associated with concussions that occur during sports competitions.
"The member's intimate knowledge and personal experience will lend Scythian and our research partners at the University of Miami great insight into the world of sports and the aftermath of head injuries. Bart Oates, who has been an Advisory Board member will head up this committee and lead in recruiting new inductees from Professional Football, Hockey, Basketball, Boxing, Soccer and more," commented Mr. Jonathan Gilbert, CEO of the Company.
About Mr. Oates
A former center for the New York Giants and San Francisco 49ers, Bart Oates is a 5-time NFL Pro Bowl player and a 3-time Super Bowl Champion. Once finished with football, Mr. Oates took law classes and then worked as an attorney, receiving his law degree from Seton Hall University. Mr. Oates maintains an active role in many services to the community, including serving as President of the NY/NJ Chapter of the NFL Alumni Association.
Stock Options
The Company has also issued 62,500 incentive stock options to an officer and advisors of the Company entitling the grantees to purchase up to 62,500 common shares of the Company at an exercise price of $8.00 per share for a period of five years. The options are subject to certain vesting provisions and are subject to regulatory approval.
About Scythian Biosciences Corp.
Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.
Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities
Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami. Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in neurocognitive testing. Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995.
Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This press release may contain certain forward-looking information and statements ("forward-looking information") within the meaning of applicable Canadian securities legislation, that are not based on historical fact, including without limitation statements containing the words "believes", "anticipates", "plans", "intends", "will", "should", "expects", "continue", "estimate", "forecasts" and other similar expressions. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, its securities, or financial or operating results (as applicable). Although the Company believes that the expectations reflected in forward-looking information in this press release are reasonable, such forward-looking information has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including the risk factors discussed in the Filing Statement and the registration statement which are incorporated herein by reference and are available through SEDAR at www.sedar.com and on the SEC EDGAR filing service at www.sec.gov. The forward-looking information contained in this press release are expressly qualified by this cautionary statement and are made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
For further information, please contact:
Scythian Biosciences Corp.
Jonathan Gilbert
CEO
Phone: (212) 729-9208
Email: info@scythianbio.com
Visit Profile page: http://www.investorideas.com/CO/SCYB/
Get News Alerts on Scythian Biosciences Corp.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
"The member's intimate knowledge and personal experience will lend Scythian and our research partners at the University of Miami great insight into the world of sports and the aftermath of head injuries. Bart Oates, who has been an Advisory Board member will head up this committee and lead in recruiting new inductees from Professional Football, Hockey, Basketball, Boxing, Soccer and more," commented Mr. Jonathan Gilbert, CEO of the Company.
About Mr. Oates
A former center for the New York Giants and San Francisco 49ers, Bart Oates is a 5-time NFL Pro Bowl player and a 3-time Super Bowl Champion. Once finished with football, Mr. Oates took law classes and then worked as an attorney, receiving his law degree from Seton Hall University. Mr. Oates maintains an active role in many services to the community, including serving as President of the NY/NJ Chapter of the NFL Alumni Association.
Stock Options
The Company has also issued 62,500 incentive stock options to an officer and advisors of the Company entitling the grantees to purchase up to 62,500 common shares of the Company at an exercise price of $8.00 per share for a period of five years. The options are subject to certain vesting provisions and are subject to regulatory approval.
About Scythian Biosciences Corp.
Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.
Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities
Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami. Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in neurocognitive testing. Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995.
Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This press release may contain certain forward-looking information and statements ("forward-looking information") within the meaning of applicable Canadian securities legislation, that are not based on historical fact, including without limitation statements containing the words "believes", "anticipates", "plans", "intends", "will", "should", "expects", "continue", "estimate", "forecasts" and other similar expressions. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, its securities, or financial or operating results (as applicable). Although the Company believes that the expectations reflected in forward-looking information in this press release are reasonable, such forward-looking information has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including the risk factors discussed in the Filing Statement and the registration statement which are incorporated herein by reference and are available through SEDAR at www.sedar.com and on the SEC EDGAR filing service at www.sec.gov. The forward-looking information contained in this press release are expressly qualified by this cautionary statement and are made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
For further information, please contact:
Scythian Biosciences Corp.
Jonathan Gilbert
CEO
Phone: (212) 729-9208
Email: info@scythianbio.com
Scythian Biosciences Corp. (TSX.V: SCYB)
is a Featured biotech and marijuana company on Investorideas.comVisit Profile page: http://www.investorideas.com/CO/SCYB/
Get News Alerts on Scythian Biosciences Corp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Subscribe to:
Posts (Atom)